Amgen | ARS: Annual Report to Security Holders
Apr 10 16:03 ET
Amgen | ARS: Annual Report to Security Holders
Mar 30, 2023 16:06 ET
Amgen | 25-NSE: Notification filed by national security exchange to report the removal from listing and registration of matured, redeemed or retired securities (and amendment thereto)
Feb 7, 2022 16:24 ET
Amgen | SC TO-T/A: Third party tender offer statement (Amendment)
Apr 16, 2021 08:39 ET
Amgen | CORRESP: CORRESP
Apr 13, 2021 16:00 ET
Amgen | SC TO-T/A: Third party tender offer statement (Amendment)
Apr 8, 2021 08:02 ET
Amgen | SC TO-T/A: Third party tender offer statement (Amendment)
Apr 6, 2021 08:01 ET
Amgen | SC TO-T/A: Third party tender offer statement (Amendment)
Mar 22, 2021 17:08 ET
Amgen | SC TO-T: Third party tender offer statement
Mar 18, 2021 08:01 ET
Amgen | SC TO-C: Written communication relating to an issuer or third party tender offer
Mar 5, 2021 16:19 ET
Amgen | SC TO-C: Written communication relating to an issuer or third party tender offer
Mar 4, 2021 17:23 ET
Amgen | SC TO-C: Written communication relating to an issuer or third party tender offer
Mar 4, 2021 08:40 ET
Amgen | UPLOAD: Others
Feb 18, 2021 17:30 ET
Amgen | CORRESP: CORRESP
Feb 9, 2021 16:56 ET
Amgen | 25: Notification of the removal from listing and registration of matured, redeemed or retired securities (and amendment thereto)
Dec 28, 2020 16:17 ET
Amgen | CERT: Others
Dec 28, 2020 16:12 ET
Amgen | PX14A6G: Notice of exempt solicitation
Apr 15, 2020 11:27 ET
Amgen | CT ORDER: Confidential Treatment Order
Oct 24, 2019 09:04 ET
Amgen | CT ORDER: Confidential Treatment Order
Jun 3, 2019 14:49 ET
Amgen | CT ORDER: Confidential Treatment Order
May 30, 2018 12:53 ET
No Data
No Data